Trials / Withdrawn
WithdrawnNCT04508933
Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS Patients
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Istanbul University - Cerrahpasa · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Covid-19 also primarily affects endothelium that line up the alveoli. The resulting hypoxemia may differ from "typical" Acute Respiratory Distress Syndrome (ARDS) due to maldistribution of perfusion related to the ventilation. Thus, pathophysiology of Covid-19 ARDS is different, which requires different interventions than typical ARDS. The investigators will assess whether extravascular lung water index and permeability of the alveolar capillary differs from typical ARDS with transpulmonary thermodilution (TPTD) technique. Extravascular Lung Water Index (EVLWI) and Pulmonary Vascular Permeability Index (PVPI) will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Extravascular Lung Water Index | Measurement of the EVLWI |
| DEVICE | Pulmonary Vascular Permeability Index | Measurement of the PVPI |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2020-09-30
- Completion
- 2020-12-31
- First posted
- 2020-08-11
- Last updated
- 2021-10-26
Locations
1 site across 1 country: Turkey (Türkiye)
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04508933. Inclusion in this directory is not an endorsement.